Vector Science & Therapeutics (TSXV: PAIN) ("Vector" or the "Company") today announced it has entered into an option agreement to purchase up to a 15% equity interest in LyoGenesis Plus for cash ...

Vector Science and Therapeutics Corp. (TSXV: PAIN) (formerly OpenSesame Acquisition Corp.) ("Vector" or the "Company") is pleased to ...

Vancouver, British Columbia--(Newsfile Corp. - April 24, 2026) - Vector Science and Therapeutics Corp. (TSXV: PAIN) (formerly OpenSesame Acquisition Corp.) ("Vector" or the "Company") is pleased to ...

Mequon-based Vector Science & Therapeutics announced that it has entered into an option agreement to purchase up to a 15% ...

LODI, Wis., Oct. 2, 2025 /CNW/ -- Vector Science & Therapeutics today announced the appointment of Tabitha Hendren as Director, Engineering and Design. Hendren will report to Chief Technology Officer ...